Clinical trials

  • CLIC-1901 CART for Acute lymphoblastic leukaemia (B-ALL)|B-cell non-Hodgkin lymphoma (including diffuse large B-cell lymphoma, Burkitt lymphoma, mantle cell lymphoma, follicular lymphoma)|Chronic lymphocytic leukaemia (CLL)/Small lymphocytic lymphoma (SLL)
  • EMPAGLIFLOZIN for Anthracycline-induced cardiotoxicity|Cancer
  • PEMBROLIZUMAB for Small cell carcinoma of the ovary (hypercalcemic type)
  • H-GLY-LYS-TYR-GLY-PHE-TYR-THR-HIS-VAL-PHE-ARG-LEU-LYS-LYS-TRP-ILE-GLN-LYS-VAL-ILE-ASP-GLN-PHE-GLY-GLU-OH for Epidermolysis bullosa|Dystrophic epidermolysis bullosa (DEB)|Junctional epidermolysis bullosa (JEB)
  • OXALIPLATIN for Small bowel adenocarcinoma
  • RO7790121 for Moderate to severe atopic dermatitis
  • DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL for Anorexia nervosa
  • Cabozantinib for Renal cell carcinoma
  • Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment for Short bowel syndrome-associated intestinal failure (SBS-IF)
  • [(1R,3S)-3-[3-[[5-(METHOXYMETHYL)-2-METHYLPYRAZOLE-3-CARBONYL]AMINO]-1H-PYRAZOL-5-YL]CYCLOPENTYL]N-PROPAN-2-YLCARBAMATE MONOHYDRATE for Advanced breast cancer | Ovarian cancer | Small cell lung cancer | Non-small cell lung cancer | Triple-negative breast cancer
  • TREMELIMUMAB for Locally advanced cholangiocarcinoma | Cholangiocarcinoma
  • GEFURULIMAB for Generalized myasthenia gravis (AChR-positive)